27.66
+0.52(+1.92%)
Currency In USD
| Previous Close | 27.14 |
| Open | 27.02 |
| Day High | 28.38 |
| Day Low | 26.99 |
| 52-Week High | 62.58 |
| 52-Week Low | 23.42 |
| Volume | 573,330 |
| Average Volume | 690,825 |
| Market Cap | 1.58B |
| PE | 2.38 |
| EPS | 11.64 |
| Moving Average 50 Days | 31.23 |
| Moving Average 200 Days | 41.04 |
| Change | 0.52 |
If you invested $1000 in Agios Pharmaceuticals, Inc. (AGIO) 10 years ago, it would be worth $258.5 as of April 19, 2025 at a share price of $27.66. Whereas If you bought $1000 worth of Agios Pharmaceuticals, Inc. (AGIO) shares 5 years ago, it would be worth $596.51 as of April 19, 2025 at a share price of $27.66.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
GlobeNewswire Inc.
Apr 17, 2025 11:00 AM GMT
CAMBRIDGE, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a con
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer
GlobeNewswire Inc.
Mar 05, 2025 10:52 PM GMT
CAMBRIDGE, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the grant of inducement equ
Agios to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Mar 04, 2025 12:00 PM GMT
CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to pres
Data not available